NCT04709835: A reported trial by Hoffmann-La Roche
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT04709835 |
|---|---|
| Title | A Phase II Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Antiviral Activity, Safety, Pharmacokinetics, and Efficacy of RO7496998 (AT-527) in Non-Hospitalized Adult Patients With Mild or Moderate COVID-19 |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 3, 2021 |
| Completion date | Sept. 17, 2021 |
| Required reporting date | Sept. 17, 2022, midnight |
| Actual reporting date | Sept. 15, 2022 |
| Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
| Days late | None |